JournalsHub
.online
Find My Journal
PC

Paul L. Crispen

University of Florida Health US

ORCID iD 0000-0002-3699-6183
213
Publications
6,236
Citations
43
H-Index
69
i10-Index
5.06
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

The Natural History of Observed Enhancing Renal Masses: Meta-Analysis and Review of the World Literature
Sam N. Chawla, Paul L. Crispen, Alexandra L. Hanlon, Richard E. Greenberg, David Y.T. Chen +1 more
The Journal of Urology 2006
714
Histological Subtype is an Independent Predictor of Outcome for Patients With Renal Cell Carcinoma
Bradley C. Leibovich, Christine M. Lohse, Paul L. Crispen, Stephen A. Boorjian, R. Houston Thompson +2 more
The Journal of Urology 2010
456
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial OA
Stephen A. Boorjian, Mehrdad Alemozaffar, Badrinath R. Konety, Neal D. Shore, Leonard G. Gomella +38 more
The Lancet Oncology 2020
419
Tumor Cell and Tumor Vasculature Expression of B7-H3 Predict Survival in Clear Cell Renal Cell Carcinoma
Paul L. Crispen, Yuri Sheinin, Timothy J. Roth, Christine M. Lohse, Susan M. Kuntz +7 more
Clinical Cancer Research 2008
271
T-Cell Coregulatory Molecule Expression in Urothelial Cell Carcinoma: Clinicopathologic Correlations and Association with Survival OA
Stephen A. Boorjian, Yuri Sheinin, Paul L. Crispen, Sara A. Farmer, Christine M. Lohse +4 more
Clinical Cancer Research 2008
271

Publications

211 total

Patient and Procedural Determinants of Postoperative Pain Trajectories PDF

Terrie Vasilopoulos, Richa Wardhan, Parisa Rashidi, Roger B. Fillingim, Margaret R. Wallace et al. - Anesthesiology, 2021
Cited by 132 OpenAlex

Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial PDF

Stephen A. Boorjian, Mehrdad Alemozaffar, Badrinath R. Konety, Neal D. Shore, Leonard G. Gomella et al. - The Lancet Oncology, 2020
Cited by 419 OpenAlex

Mechanisms of immune evasion in bladder cancer PDF

Paul L. Crispen, Sergei Kusmartsev - Cancer Immunology Immunotherapy, 2019
Cited by 242 OpenAlex

Histological Subtype is an Independent Predictor of Outcome for Patients With Renal Cell Carcinoma

Bradley C. Leibovich, Christine M. Lohse, Paul L. Crispen, Stephen A. Boorjian, R. Houston Thompson et al. - The Journal of Urology, 2010
Cited by 456 OpenAlex

Lymph Node Dissection at the Time of Radical Nephrectomy for High-Risk Clear Cell Renal Cell Carcinoma: Indications and Recommendations for Surgical Templates

Paul L. Crispen, Rodney H. Breau, Cristine Allmer, Christine M. Lohse, John C. Cheville et al. - European Urology, 2010
Cited by 177 OpenAlex

Outcome of Stage T2 or Greater Renal Cell Cancer Treated With Partial Nephrectomy

Rodney H. Breau, Paul L. Crispen, Rafael E. Jiménez, Christine M. Lohse, Michael L. Blute et al. - The Journal of Urology, 2010
Cited by 163 OpenAlex

The Impact of Positive Surgical Margins on Mortality Following Radical Prostatectomy During the Prostate Specific Antigen Era

Stephen A. Boorjian, R. Jeffrey Karnes, Paul L. Crispen, Rachel E. Carlson, Laureano J. Rangel et al. - The Journal of Urology, 2010
Cited by 133 OpenAlex

Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance PDF

Paul L. Crispen, Rosalia Viterbo, Stephen A. Boorjian, Richard E. Greenberg, David Y.T. Chen et al. - Cancer, 2009
Cited by 197 OpenAlex

Radiation Therapy After Radical Prostatectomy: Impact on Metastasis and Survival

Stephen A. Boorjian, R. Jeffrey Karnes, Paul L. Crispen, Laureano J. Rangel, Eric J. Bergstralh et al. - The Journal of Urology, 2009
Cited by 107 OpenAlex

Tumor Cell and Tumor Vasculature Expression of B7-H3 Predict Survival in Clear Cell Renal Cell Carcinoma

Paul L. Crispen, Yuri Sheinin, Timothy J. Roth, Christine M. Lohse, Susan M. Kuntz et al. - Clinical Cancer Research, 2008
Cited by 271 OpenAlex

Research Topics

Renal cell carcinoma treatment (80) Bladder and Urothelial Cancer Treatments (64) Renal and related cancers (51) Cancer Immunotherapy and Biomarkers (32) Immune cells in cancer (28)

Frequent Co-Authors

ST
Stephen A. Boorjian
7 joint publications
MI
Michael L. Blute
6 joint publications
RO
Robert G. Uzzo
5 joint publications
BR
Bradley C. Leibovich
5 joint publications
CH
Christine M. Lohse
5 joint publications
RI
Richard E. Greenberg
4 joint publications

Affiliations

Fox Chase Cancer Center
US 2020 - 2005
Mayo Clinic
US 2011 - 2008
University of Kentucky
US 2014 - 2010
Emory University
US 2025 - 2025
University of Michigan–Ann Arbor
US 2008 - 2008

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now